Laboratorios Farmaceuticos Rovi, S.A. specializes in the research, development, manufacturing and marketing of biological medications and specialty drugs. Net sales break down by family of products as follows:
- pharmaceutical products manufactured under contract (49.3%);
- prescription pharmaceuticals (45.6%): intended for preventing and treating venous thrombo-embolic disease, post-menopausal osteoporosis, muscle pain, tooth and mouth infections, angina, osteoarthritis, etc.;
- diagnostic products (4.9%): contrast products used in medical imaging with magnetic resonance, ultrasound, or X-rays;
- OTC products (0.2%): intended for easing the symptoms of menopause, controlling excessive transpiration, balancing hormone levels in the body, hydrating and protecting the skin, etc.
Income by source of revenue breaks down between sales of products (50.5%), sales of services (49.4%) and sales of licenses (0.1%).
Net sales are distributed geographically as follows: Spain (32.3%), European Union (16.7%), OECD countries (46.1%) and other (4.9%).
More about the company